Financial reports
ARS
2023 FY
Annual report to shareholders
8 Apr 24
10-K
2023 FY
Annual report
16 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
4 Apr 23
10-K
2022 FY
Annual report
21 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
Current reports
8-K
Other Events
22 Apr 24
8-K
Regulation FD Disclosure
12 Apr 24
8-K
Excluding a $725 Million Increase to the Fdic Special Assessment, Net Income of
12 Apr 24
8-K
Departure of Directors or Certain Officers
8 Apr 24
8-K
Other Events
21 Mar 24
8-K
Material Modifications to Rights of Security Holders
12 Mar 24
8-K
Other Events
25 Jan 24
8-K
Other Events
23 Jan 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K
Departure of Directors or Certain Officers
16 Jan 24
Registration and prospectus
FWP
Free writing prospectus
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
424B2
Prospectus for primary offering
24 Apr 24
Proxies
PX14A6G
Letter to shareholders
24 Apr 24
PX14A6G
Letter to shareholders
23 Apr 24
PX14A6G
Letter to shareholders
22 Apr 24
PX14A6G
Letter to shareholders
12 Apr 24
DEFA14A
Additional proxy soliciting materials
8 Apr 24
DEF 14A
Definitive proxy
8 Apr 24
PX14A6G
Letter to shareholders
27 Mar 24
PX14A6G
Letter to shareholders
12 May 23
PX14A6G
Letter to shareholders
11 May 23
DEFA14A
Additional proxy soliciting materials
11 May 23
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
16 Feb 24
EFFECT
Notice of effectiveness
7 Feb 24
CERT
Certification of approval for exchange listing
26 Jan 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Nov 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3 Aug 23
EFFECT
Notice of effectiveness
14 Apr 23
CORRESP
Correspondence with SEC
10 Apr 23
UPLOAD
Letter from SEC
3 Mar 23
EFFECT
Notice of effectiveness
12 Apr 22
CORRESP
Correspondence with SEC
7 Apr 22
Ownership
4
JAMES DIMON
19 Apr 24
4
JAMES DIMON
15 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
SC 13G/A
Revance Therapeutics, Inc.
9 Apr 24
SC 13G/A
RAYONIER INC
9 Apr 24
SC 13G/A
PMV Pharmaceuticals, Inc.
9 Apr 24
SC 13G/A
NORFOLK SOUTHERN CORP
9 Apr 24
SC 13G/A
Information Services Group Inc.
9 Apr 24
SC 13G/A
GENESIS ENERGY LP
9 Apr 24
SC 13G/A
Evolent Health, Inc.
9 Apr 24